1. Bcl-2 antagonist killer 1 (BAK1) polymorphisms influence the risk of developing autoimmune rheumatic diseases in women. Issue 2 (11th March 2009) Authors: Delgado-Vega, A M; Castiblanco, J; Gómez, L M; Diaz-Gallo, L-M; Rojas-Villarraga, A; Anaya, J-M Journal: Annals of the rheumatic diseases Issue: Volume 69:Issue 2(2010) Page Start: 462 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk. Issue 11 (19th November 2008) Authors: Abelson, A-K; Delgado-Vega, A M; Kozyrev, S V; Sánchez, E; Velázquez-Cruz, R; Eriksson, N; Wojcik, J; Linga Reddy, M V P; Lima, G; D'Alfonso, S; Migliaresi, S; Baca, V; Orozco, L; Witte, T; Ortego-Centeno, N; Abderrahim, H; Pons-Estel, B A; Gutiérrez, C; Suárez, A; González-Escribano, M F Journal: Annals of the rheumatic diseases Issue: Volume 68:Issue 11(2009) Page Start: 1746 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗